Malignant epithelioid angiomyolipoma in the kidney and liver of a patient with pulmonary lymphangioleiomyomatosis: Lack of response to sirolimus

Internal Medicine

Volumn 48, Issue 20, 2009, Pages 1821-1825

  Higa, Futoshi ^a   Uchihara, Teruhito ^a   Haranaga, Syusaku ^a   Yara, Satomi ^a   Tateyama, Masao ^a   Oshiro, Yoshinori ^a   Shiraishi, Masayuki ^a   Kumasaka, Toshio ^a,b   Seyama, Kuniaki ^b   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Angiomyolipoma; Epithelioid variant; Gefitinib; Lymphangioleiomyomatosis; Sirolimus

Indexed keywords

C REACTIVE PROTEIN; GEFITINIB; LACTATE DEHYDROGENASE; RAPAMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANGIOMYOLIPOMA; ARTICLE; AUTOPSY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE INCREASE; ENZYME ACTIVITY; EPITHELIOID CELL; FEMALE; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY HEMANGIOMYOLIPOMA; KIDNEY TUMOR; LEUKOCYTOSIS; LIVER ANGIOMYOLIPOMA; LUNG BIOPSY; LYMPHANGIOLEIOMYOMATOSIS; METASTASIS POTENTIAL; PNEUMOTHORAX; PROTEIN BLOOD LEVEL; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; RESPIRATORY FAILURE; THORAX PAIN; THORAX RADIOGRAPHY; TUMOR VOLUME; URINALYSIS;

ADULT; ANGIOMYOLIPOMA; FATAL OUTCOME; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; NEOPLASM RECURRENCE, LOCAL; SIROLIMUS;

EID: 71049172149     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2411     Document Type: Article

References (20)

1. De Pauw RA, Boelaert JR, Haenebalcke CW, Matthys EG, Schurgers MS, De Vriese AS. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis. Am J Kidney Dis 41: 877-883, 2003.
2. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and pr.edictive factors. Kidney Int 70: 1777-1782, 2006.
3. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 355: 1345-1356, 2006.
4. Kenerson H, Folpe AL, Takayama TK, Yeung RS. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol 38: 1361-1371, 2007.
5. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358: 140-151, 2008.
6. Stone CH, Lee MW, Amin MB, et al. Renal angiomyolipoma: Further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125: 751-758, 2001.
7. Brian RL, Aydin H, Danforth TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: Classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180: 836-843, 2008.
8. Park HK, Zhang S, Wong MK, Kim HL. Clinical presentation of epithelioid angiomyolipoma. Int J Urol 14: 21-25, 2007.
9. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361: 1348-1349, 2003.
10. Schroeder M, Aul C. Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis. Aktuelle Urol 36: 430-432, 2005.
11. Inci O, Kaplan M, Yalcin O, Atakan IH, Kubat H. Renal angiomyolipoma with malignant transformation, simultaneous occurrence with malignity and other complex clinical situations. Int Urol Nephrol 38: 417-426, 2006.
12. Takahashi N, Kitahara R, Hishimoto Y, Ohguro A, Hashimoto Y, Suzuki T. Malignant transformation of renal angiomyolipoma. Int J Urol 10: 271-273, 2003.
13. Kawaguchi K, Oda Y, Nakanishi K, et al. Malignant transformation of renal angiomyolipoma: A case report. Am J Surg Pathol 26: 523-529, 2002.
14. Martignoni G, Pea M, Rigaud G, et al. Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: Demonstration of the same genetic defects in the primary and metastatic lesions. Am J Surg Pathol 24: 889-894, 2000.
15. Christiano AP, Yang X, Gerber GS. Malignant transformation of renal angiomyolipoma. J Urol 161: 1900-1901, 1999.
16. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 97: 6085- 6090, 2000.
17. Davies DM, Johnson SR, Tattersfield AE, et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med 358: 200-203, 2008.
18. Lesma E, Grande V, Carelli S, et al. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: Epidermal growth factor is the required growth factor. Am J Pathol 167: 1093-1103, 2005.
19. Lim SD, Kim W, Ahn G, Kwon GY. Protein expression and mutational analysis of epidermal growth factor receptor in renal angiomyolipomas. Pathol Int 57: 584-588, 2007.
20. Yu J, Astrinidis A, Howard S, Henske EP. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol 286: L694-L700, 2004.